1. Home
  2. CELU vs CLRO Comparison

CELU vs CLRO Comparison

Compare CELU & CLRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Celularity Inc.

CELU

Celularity Inc.

N/A

Current Price

$0.70

Market Cap

17.3M

Sector

Health Care

ML Signal

N/A

Logo ClearOne Inc. (DE)

CLRO

ClearOne Inc. (DE)

N/A

Current Price

$4.94

Market Cap

17.0M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
CELU
CLRO
Founded
2016
1983
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Radio And Television Broadcasting And Communications Equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
17.3M
17.0M
IPO Year
2019
2018

Fundamental Metrics

Financial Performance
Metric
CELU
CLRO
Price
$0.70
$4.94
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$6.00
N/A
AVG Volume (30 Days)
35.5K
1.7M
Earning Date
05-11-2026
05-18-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$26,550,000.00
$46,067,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$76.00
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
11.59
52 Week Low
$0.56
$2.71
52 Week High
$4.15
$16.50

Technical Indicators

Market Signals
Indicator
CELU
CLRO
Relative Strength Index (RSI) 50.49 45.61
Support Level $0.69 $3.97
Resistance Level $0.85 $4.98
Average True Range (ATR) 0.06 1.45
MACD 0.00 -0.15
Stochastic Oscillator 66.20 13.15

Price Performance

Historical Comparison
CELU
CLRO

About CELU Celularity Inc.

Celularity Inc is a regenerative and cellular medicine company focused on developing placental-derived allogeneic cell therapies and biomaterial products for the treatment of degenerative diseases, aging-related conditions, cancer, and immune disorders. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. It generates the majority of its revenue from the Degenerative Disease segment.

About CLRO ClearOne Inc. (DE)

ClearOne Inc is currently engaged in activities that consist solely of fulfilling warranty and technical support obligations on legacy products, evaluating potential Strategic Transactions, managing and liquidating remaining assets of the company's legacy operating business, collecting accounts receivable and recovering prepaid assets, satisfying outstanding liabilities, and maintaining public-company compliance.

Share on Social Networks: